Allegheny Financial Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-554
Closed -$284K 167
2022
Q4
$284K Hold
554
0.12% 129
2022
Q3
$251K Hold
554
0.12% 127
2022
Q2
$267K Hold
554
0.12% 123
2022
Q1
$272K Hold
554
0.12% 125
2021
Q4
$257K Hold
554
0.1% 132
2021
Q3
$207K Hold
554
0.09% 138
2021
Q2
$212K Sell
554
-5
-0.9% -$1.91K 0.1% 137
2021
Q1
$201K Buy
+559
New +$180K 0.15% 94

Other funds holding ELV

Allegheny Financial Group's ELV Position: Q1 2023 in Review

Allegheny Financial Group sold out of Elevance Health (ELV) in Q1 2023, closing a stake of 554 shares — an estimated $284K sold.

Allegheny Financial Group first reported a position in ELV in Q1 2021 and held it in 8 quarters. The position peaked at $284K in Q4 2022. 1,516 funds tracked by Wall St. Rank hold ELV as of Q1 2023.

  • Allegheny Financial Group reported no remaining Elevance Health position as of Q1 2023 after selling out during the quarter.
  • Allegheny Financial Group sold 554 Elevance Health shares in Q1 2023, an estimated $284K.
  • Allegheny Financial Group first reported a position in Elevance Health in Q1 2021 and held it in 8 quarters.
  • Allegheny Financial Group's Elevance Health position peaked at $284K in Q4 2022.
  • 1,516 funds tracked by Wall St. Rank held Elevance Health as of Q1 2023.

Based on Allegheny Financial Group's 13F filing for Q1 2023, filed 5 May 2023.